Idarucizumab for a traumatic head injury patient taking dabigatran

Idarucizumab for a traumatic head injury patient taking dabigatran

Abstract Background Dabigatran is one of the four drugs currently used as a direct oral anticoagulant in Japan. Idarucizumab, which specifically targets dabigatran, was recently approved in Japan. We present a case of intracranial hemorrhage in a traumatic brain injury patient taking dabigatran who...

Full description

Bibliographic Details
Main Authors: Shuhei Maruyama, Koichi Hayakawa, Shuji Kanayama, Hiromu Iwamura, Daiki Wada, Fukuki Saito, Yasushi Nakamori, Yasuyuki Kuwagata
Format: Article
Language:English
Published: BMC 2018-10-01
Series:International Journal of Emergency Medicine
Subjects:
Dabigatran
Direct oral anticoagulants
Idarucizumab
Specific neutralizing drug
Traumatic brain injury
Traumatic intracranial hemorrhage
Online Access:http://link.springer.com/article/10.1186/s12245-018-0202-y

Internet

http://link.springer.com/article/10.1186/s12245-018-0202-y

Similar Items